<DOC>
	<DOCNO>NCT01340157</DOCNO>
	<brief_summary>The present study design assess impact concomitant food intake relative bioavailability single oral fexinidazole tablet administration .</brief_summary>
	<brief_title>Fexinidazole ( 1200mg ) Bioavailability Under Different Food Intake Conditions</brief_title>
	<detailed_description />
	<criteria>Male healthy volunteer 18 45 year age , All subject subSaharan African origin parent sub Saharan African origin , Male subject body mass index ( BMI ) calculate weight kg/ ( height m2 ) 18 28 kg/m2 screening , Able communicate well Investigator research staff comply requirement entire study , Provision write informed consent participate show signature volunteer consent form , Light smoker ( less 10 cigarette per day ) subject nonsmoker . No smoking ( use smoke substitute e.g . nicotine patch ) permit screen throughout study , Normal arterial blood pressure ( BP ) pulse rate , abnormal , consider clinically significant principal Investigator . These measure rest 5 min , Registered French Social Security agreement French law biomedical experimentation . Who direct question physical examination evidence clinically significant acute chronic disease , include know suspected Human Immunodeficiency Virus ( HIV ) , Hepatitis B Virus ( HBV ) Hepatitis C Virus ( HCV ) infection , With clinically significant abnormality follow review prestudy laboratory test ( aspartate aminotransferase ( ASAT ) , alanine aminotransferase ( ALAT ) alkaline phosphatase ( ALP ) must within normal range ) , vital sign , full physical examination Electrocardiogram ( ECG ) , Who within exclusion period define National Register Healthy Volunteers French Ministry Health , Who forfeit freedom administrative legal award guardianship , Unwilling give inform consent , Who positive laboratory test Hepatitis B surface antigen ( HbsAg ) , antiHIV 1/2 anti HCV antibody Who history allergy , intolerance photosensitivity drug , Who history serious allergy , asthma , allergic skin rash sensitivity drug , Who know suspected alcohol drug abuser ( 14 unit alcohol per week , one unit = 8 g 10 mL pure alcohol ) , Who drink 8 cup daily beverage contain caffeine , Who positive laboratory test urine drug screening ( opiate , cocaine , amphetamine , cannabis , benzodiazepine ) , Who undergo surgery donate blood within 12 week prior start study , Who take prescribed counter drug ( include antacid drug ) , exception paracetamol ( 3 g per day ) within 2 week prior first dose administration , Who clinical condition prior therapy , opinion Investigator , make subject unsuitable study , Who participate clinical trial investigational drug past 3 month precede study entry .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>April 2011</verification_date>
	<keyword>Fexinidazole</keyword>
	<keyword>Phase I</keyword>
	<keyword>Bioavailability study</keyword>
	<keyword>Food effect</keyword>
	<keyword>Human African Trypanosomiasis</keyword>
</DOC>